Inventor · disambiguated record
Sven Hellberg
Also filed as: HELLBERG SVEN
11 granted patents·18 pending applications·78 citations·filing 2002–2010
89Inventor score
Top patents by PatentIndex Score
29 records- 0182US7595319B2Compounds having selective inhibiting effect at GSK3ASTRAZENECA AB·Filed 2003·Granted Sep 29, 2009·15 cites·3 claims
- 0278US7585853B2Compounds having selective inhibiting effect at GSK3ASTRAZENECA AB·Filed 2003·Granted Sep 8, 2009·9 cites·2 claims
- 0377US7399780B23-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3ASTRAZENECA AB·Filed 2003·Granted Jul 15, 2008·12 cites·15 claims
- 0476US7205314B2Compounds for the treatment of dementia related diseasesASTRAZENECA AB·Filed 2002·Granted Apr 17, 2007·12 cites·8 claims
- 0574US7342022B2Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3ASTRAZENECA AB·Filed 2002·Granted Mar 11, 2008·9 cites·1 claims
- 0672US7078410B22-arylamino-pyrimidines for the treatment of GSK3-related disordersASTRAZENECA AB·Filed 2002·Granted Jul 18, 2006·7 cites·10 claims
- 0770US7595321B2Compounds having selective inhibiting effect at GSK3ASTRAZENECA AB·Filed 2003·Granted Sep 29, 2009·4 cites·7 claims
- 0869US7056939B24-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)ASTRAZENECA AB·Filed 2002·Granted Jun 6, 2006·4 cites·10 claims
- 0968US6747060B2Non-natural galanin receptor ligandsKEMIA INC·Filed 2002·Granted Jun 8, 2004·4 cites·59 claims
- 1062US7683067B23-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)ASTRAZENECA AB·Filed 2004·Granted Mar 23, 2010·1 cites·9 claims
- 1161US7345050B2Pyrimidine compoundsASTRAZENECA AB·Filed 2002·Granted Mar 18, 2008·1 cites·5 claims
- 1260US2010081660A1Novel Compounds Having Selective Inhibiting Effect at GSK3BERG STEFAN·Filed 2009·Application pending·0 cites
- 1360US2010075989A1Novel Compounds Having Selective Inhibiting Effect at GSK3ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1457US2009312322A1Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1554US2009149460A1New CompoundsBERG STEFAN·Filed 2008·Application pending·0 cites
- 1652US2006194854A1New 2-substituted - 1,3-thiazole compoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1751US2008214560A1Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's DiseaseASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1848US2005119321A12-substituted-1,3-thiazole compoundsFiled 2003·Application pending·0 cites
- 1947US2009233943A9New compounds 835ASTEX THERAPEUTICS LTD·Filed 2008·Application pending·0 cites
- 2046US2005070559A1Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3Filed 2002·Application pending·0 cites
- 2143US2009233930A9Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and DementiaASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2243US2009023762A1Substituted 2-Aminopyrimidine-4-Ones, Their Pharmaceutical Compositions And Their Use In The Treatment And/Or Prevention Of Ab-Related PathologiesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2341US2006052396A1Arylamines for the treatment of conditions associated with gsk-3BERG STEFAN·Filed 2002·Application pending·0 cites
- 2441US2011028489A1Pyrimidine Derivatives and Their Use for Treating Bone-Related DisordersANDERSSON LARS·Filed 2010·Application pending·0 cites
- 2541US2004186113A1Heterocyclic amines for the treatment of conditions associated with gsk-3Filed 2002·Application pending·0 cites
- 2641US2009105252A1Pyrimidine Derivatives and Their Use in Therapy as well as the Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's DiseaseASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2741US2005075351A1UseFiled 2002·Application pending·0 cites
- 2840US2009099217A12-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related PathologiesASTEX THERAPEUTICS LTD·Filed 2007·Application pending·0 cites
- 2936US2009018130A1Derivatives of 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxamide or 5-Aryl-1H-Pyrrolo [2, 3B] Pyridine-3-Carboxylic AcidBERG STEFAN·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sven Hellberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →